Keyword: United States

Oncology tests in the U.S. are still failing to adequately represent racial diversity, and more needs to be done to help combat this disparity.

Chinese conglomerate Fosun has struck deals with Kite and other U.S. biotechs in the past but now plans to limit its activities in the country.

The East Coast investor will primarily provide debt financing to enable companies to reach milestones with minimal equity dilution.

Ochsner Health System tapped Geneva Health Solutions to manage data collection and remote monitoring of its patients with implanted cardiac devices.

The small phase 2 feasibility study linked fixed-dose combination NRX-101 to improved scores on a depression rating scale.

Medtronic will pay nearly $51 million to settle claims against two of its acquisitions related to unapproved device promotions and alleged kickbacks.

Specialized implant manufacturer ChoiceSpine was acquired by Altus Capital Partners, marking the firm’s second medtech acquisition in two years.

The all-cash deal will give Symmetry Surgical ownership of the Bovie brand and devices used in electrosurgical procedures.

The plan is to “cross reference people’s genetics, habits and medical records" along with national data to spot cancer early.

The cell-sampling device is an encapsulated balloon that can quickly gather samples from the distal esophagus when swallowed.